Navigation Links
Omeros Elucidates Mechanism of its PDE7 Inhibitors in Addiction
Date:3/19/2013

SEATTLE, March 19, 2013 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER) today announced that it has elucidated the mechanism of action of its phosphodiesterase 7 (PDE7) inhibitors in the neural network shown to be responsible for addiction in humans. Omeros believes that it is the first to discover the link between PDE7 and any addiction or compulsive disorder, and the Company is establishing a broad intellectual property position around this discovery. Omeros expects to submit an Investigational New Drug application or the European equivalent for its lead PDE7 inhibitor (OMS527) to permit the initiation of human clinical trials later this year.

Most, if not all, addictions and compulsions are directly tied to increased release of dopamine in the brain. Through an extensive battery of behavioral, electrophysiological and neurotransmitter studies in animals, Omeros identified the mechanism by which its proprietary PDE7 inhibitors reduce the heightened dopamine release caused by drugs of abuse. These studies generated consistent data demonstrating that Omeros' PDE7 inhibitors are effective in nicotine, cocaine, opioid and alcohol addiction as well as in binge eating and uncovered the activities of these compounds at specific sites within the neural network that controls addiction. These same neural pathways have been shown to be responsible for addictions and compulsive behaviors in humans.

"The mechanism by which our PDE7 inhibitors work in addiction cuts across multiple drugs of abuse," stated Gregory A. Demopulos , M.D., chairman and chief executive officer of Omeros. "With almost 1.5 billion nicotine addicts, 140 million alcoholics, 15 million cocaine addicts and 6 million opioid addicts worldwide, the addiction problem – and the pharmaceutical industry's interest in treating that problem – is grow
'/>"/>

SOURCE Omeros Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Omeros to Present at Deutsche Bank Securities Health Care Conference
2. Omeros Adds Four More Unlocked Orphan GPCRs to its Portfolio
3. Omeros to Present at Jefferies 2012 Global Healthcare Conference
4. Omeros Announces Proposed Public Offering of Common Stock
5. Omeros Prices $30 Million Public Offering of Common Stock
6. Omeros Announces Closing of $34.5 Million Public Offering of Common Stock
7. Omeros Successfully Completes Preclinical Studies of OMS824 for Schizophrenia and Phase 1 Clinical Trial Preparations Underway
8. Omeros Announces Discovery in MASP-2 Program
9. Omeros Corporation Reports Second Quarter 2012 Financial Results
10. Omeros Announces Completion of Enrollment in OMS103HP Phase 3 Clinical Trial
11. Omeros to Present at Two Upcoming Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... CYBX ) today announced results for the quarter ended ... Operating results for the first quarter of fiscal ... other achievements, include: , Worldwide net product sales of ... net sales of $13.2 million, an increase of 14.5% on ... reached a new high of $58.8 million, an increase of ...
(Date:8/21/2014)... , Aug. 21, 2014   Auxilium Pharmaceuticals, ... specialty biopharmaceutical company, today announced positive results from ... clostridium histolyticum (or CCH) for the treatment of ... In the Phase 2a trial, all three doses ... (0.84mg)) showed an improvement in the appearance of ...
(Date:8/20/2014)... , Aug. 20, 2014  The National Association ... latest results achieved by the real-time, pseudoephedrine (PSE) ... National Precursor Log Exchange (NPLEx), automatically blocks unlawful ... down meth offenders and make arrests. Data released ... Kentucky blocked the sale of more ...
Breaking Medicine Technology:Cyberonics Reports Fiscal 2015 First Quarter Results 2Cyberonics Reports Fiscal 2015 First Quarter Results 3Cyberonics Reports Fiscal 2015 First Quarter Results 4Cyberonics Reports Fiscal 2015 First Quarter Results 5Cyberonics Reports Fiscal 2015 First Quarter Results 6Cyberonics Reports Fiscal 2015 First Quarter Results 7Cyberonics Reports Fiscal 2015 First Quarter Results 8Cyberonics Reports Fiscal 2015 First Quarter Results 9Cyberonics Reports Fiscal 2015 First Quarter Results 10Cyberonics Reports Fiscal 2015 First Quarter Results 11Cyberonics Reports Fiscal 2015 First Quarter Results 12Cyberonics Reports Fiscal 2015 First Quarter Results 13Cyberonics Reports Fiscal 2015 First Quarter Results 14Cyberonics Reports Fiscal 2015 First Quarter Results 15Cyberonics Reports Fiscal 2015 First Quarter Results 16Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 2Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 3Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 4Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 5Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 6Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 7Kentucky's Stop-Sale System Achieves Significant Results In Battle Against Meth 2
... genetics,(Nasdaq: DCGN ) today announced the filing ... the company,s novel small-molecule modulator,of phosphodiesterase 4 (PDE4), ... compound is being developed as a new and ... loss and cognitive deficits associated,with Alzheimer,s disease and ...
... from the,French Medicine Agency (AFSSAPS) the authorization to ... PL37, its lead compound for oral,treatment of neuropathic ... pain condition, with an estimated,prevalence in the world,s ... most,recent surveys, with many causes such as shingles, ...
Cached Medicine Technology:deCODE Files IND for DG071, a Novel PDE4 Modulator Being Developed for Alzheimer's and Other Cognitive Disorders 2deCODE Files IND for DG071, a Novel PDE4 Modulator Being Developed for Alzheimer's and Other Cognitive Disorders 3deCODE Files IND for DG071, a Novel PDE4 Modulator Being Developed for Alzheimer's and Other Cognitive Disorders 4deCODE Files IND for DG071, a Novel PDE4 Modulator Being Developed for Alzheimer's and Other Cognitive Disorders 5Pharmaleads' Lead Candidate for Pain, PL37, Enters Phase I 2
(Date:8/21/2014)... While golfing in Scotland and abroad, Biteback ... focused on his game due to the incessant buzzing ... and continual need to spray insect repellent became so ... from insects while golfing. He ultimately found a solution ... Banking Industry, decided to change direction and launch Biteback ...
(Date:8/21/2014)... (PRWEB) August 21, 2014 Denver ... Inspirational Sponsor for the American Lung Association in Colorado’s ... thrilled to welcome Webolutions as a sponsor,” said Curt ... Southwest, and Executive Director, American Lung Association in Colorado, ... the table in this role they’ve defined.” , Webolutions ...
(Date:8/21/2014)... HIPAA Secure Now! rolled out its EHR (electronic ... vendors to now offer their customers a HIPAA security ... , HIPAA Secure Now! provides risk analysis services, ... U.S. The company assesses the risks of storing and ... and device used by the practice. , HIPAA ...
(Date:8/21/2014)... 2014 Consilium Staffing, Your Partner in ... temporary physicians in response to the President’s landmark VA ... billion to the Department of Veterans Affairs to hire ... more than one hundred fifty medical centers nationwide, and ... of patients awaiting treatment, including vets from the Vietnam ...
(Date:8/21/2014)... (PRWEB) August 21, 2014 The employees ... Historic Park in Washington Crossing, Pennsylvania on Thursday, August ... park. “We have been looking for different ways that ... Matt Kiernan, Partner with Pharmica Consulting. “When we heard ... of U.S. history, we jumped at the opportunity.” , ...
Breaking Medicine News(10 mins):Health News:Financial VP Fights Pesky Bugs with Launch of Biteback Sports Insect Shield® Golf Apparel 2Health News:Denver Marketing Agency Webolutions Named Inspirational Sponsor for 2014 Run the ‘Rocks 5K 2Health News:Denver Marketing Agency Webolutions Named Inspirational Sponsor for 2014 Run the ‘Rocks 5K 3Health News:HIPAA Secure Now! Ramps up EHR Partner Program, Helps Healthcare Providers Achieve Meaningful Use under Revised CMS Deadlines 2Health News:Consilium Staffing Providing Locum Tenens in Response to VA Hospital Reform Legislation 2Health News:Pharmica Spends the Day Helping to Preserve Washington Crossing Historic Park 2
... , WASHINGTON, July 30 An estimated ... if Congress passes a House health reform bill, according to ... 2009 released this week by The Heritage ... The Lewin Group , a highly respected health ...
... , , WASHINGTON, July 30 ... today launched new tools and services designed to help independent retail ... communities. , , With a conference theme of ... the nation,s capitol to underscore its continued commitment to creating successful, ...
... to an evolutionary event , THURSDAY, July 30 (HealthDay ... distinctively short legs following a single change to the ... that may also help explain a type of human ... Institute (NHGRI) found that about 20 short-legged dog breeds, ...
... , - New NMA President to Address Health ... LAS VEGAS, July 30 Delivering her inaugural address as ... Edwards, MD, MBA, shared her plans to focus on health care ... nation,s premier organization for African American physicians. , , ...
... July 30 Human pheromones are over-stated, or are they? ... to whether or not human pheromones exist, and, if they do, exactly ... the lay community, pheromones are thought of as sexual ... the research and education division of The Fragrance Foundation, turned to ...
... from sunlight may be associated with the development of ... study by researchers at the National Institute of Environmental ... Health. "This study found that women who lived ... they developed an autoimmune muscle disease called myositis were ...
Cached Medicine News:Health News:Millions of Virginians Could Lose Private Insurance, Study Shows 2Health News:Cardinal Health Welcomes Record Number of Attendees at its Annual Independent Pharmacy Trade Show 2Health News:Cardinal Health Welcomes Record Number of Attendees at its Annual Independent Pharmacy Trade Show 3Health News:Cardinal Health Welcomes Record Number of Attendees at its Annual Independent Pharmacy Trade Show 4Health News:Researchers Discover the Tale Behind Short Dogs 2Health News:National Medical Association Installs 110th President at Las Vegas Convention 2Health News:Sun exposure may trigger certain autoimmune diseases in women 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: